These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 6702859)

  • 21. Hypertension Drug Therapy.
    Hui R
    Adv Exp Med Biol; 2020; 1177():149-268. PubMed ID: 32246447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New insights and new approaches for the treatment of essential hypertension: selection of therapy based on coronary heart disease risk factor analysis, hemodynamic profiles, quality of life, and subsets of hypertension.
    Houston MC
    Am Heart J; 1989 Apr; 117(4):911-51. PubMed ID: 2648781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized controlled trials of blood pressure lowering in hypertension: a critical reappraisal.
    Zanchetti A; Thomopoulos C; Parati G
    Circ Res; 2015 Mar; 116(6):1058-73. PubMed ID: 25767290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypertension--when is the clinical problem solved? When patients are rendered normotensive.
    Mancia G; Lanfranchi A; Cattaneo BM; Grassi G
    Cardiology; 1994; 85 Suppl 1():58-64. PubMed ID: 7743536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statins in hypertension: are they a new class of antihypertensive agents?
    Feldstein CA
    Am J Ther; 2010; 17(3):255-62. PubMed ID: 19918164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benefits of antihypertensive drugs when blood pressure is below 140/90 mmHg.
    Izzo JL
    Pol Arch Med Wewn; 2011 Sep; 121(9):303-9. PubMed ID: 21952525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of ARBs alone or with HCTZ in the treatment of hypertension and prevention of cardiovascular and renal complications.
    Greathouse MK; Weir MR
    Postgrad Med; 2012 Mar; 124(2):40-52. PubMed ID: 22437214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypertension and coronary heart disease risk factor management.
    Houston MC
    Clin Auton Res; 1993 Dec; 3(6):357-61. PubMed ID: 8193521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.
    Leenen FH
    Can J Cardiol; 2004 Aug; 20 Suppl B():77B-82B. PubMed ID: 15309209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Heart, brain and hypertension].
    Lüscher TF; Sturzenegger M; Noll G
    Schweiz Med Wochenschr; 1996 Aug; 126(34):1449-56. PubMed ID: 8848709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk stratification for the prevention of cardiovascular complications of hypertension.
    Girerd X; Giral P
    Curr Med Res Opin; 2004 Jul; 20(7):1137-42. PubMed ID: 15265258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clevidipine: a review of its use in the management of acute hypertension.
    Deeks ED; Keating GM; Keam SJ
    Am J Cardiovasc Drugs; 2009; 9(2):117-34. PubMed ID: 19331440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.
    JAMA; 2000 Apr; 283(15):1967-75. PubMed ID: 10789664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New goals in hypertension management: target-organ protection beyond blood pressure lowering].
    Safar ME; Struijker-Boudier HA
    Drugs; 2003; 63 Spec No 1():45-7. PubMed ID: 12708882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diuretics in cardiovascular therapy. Perusing the past, practising in the present, preparing for the future.
    Taylor SH
    Z Kardiol; 1985; 74 Suppl 2():2-12. PubMed ID: 3890392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modification of cardiovascular risk factors during antihypertensive treatment: current and new approach trends. The urapidil experience.
    Leonetti G
    Blood Press Suppl; 1994; 4():49-52. PubMed ID: 7804513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Has antihypertensive treatment prevented vascular disease or vascular events?
    Zanchetti A
    J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S1-5. PubMed ID: 1376826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implications of the primary prevention trials against coronary heart disease.
    Kannel WB
    J Hypertens Suppl; 1990 Dec; 8(7):S245-50. PubMed ID: 1982770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of increased heart rate on clinical outcomes in hypertension: implications for antihypertensive drug therapy.
    Palatini P; Benetos A; Julius S
    Drugs; 2006; 66(2):133-44. PubMed ID: 16451089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of hypertension and antihypertensive drugs on cardiovascular complications in the elderly.
    Kuramoto K; Matsushita S; Shibata H
    Jpn Circ J; 1988 Jan; 52(1):1-8. PubMed ID: 3361687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.